赵俊杰：人工智能、半导体等驱动科技驱动未来经济新图景

Core Insights - The 2025 Global Investor Conference held by the Shenzhen Stock Exchange focused on "New Quality Productivity: Investment Opportunities in China" and showcased the investment value of Chinese assets and the A-share market [1] Industry Insights - The CEO of Swiss Pictet Asset Management highlighted four promising sectors in China: artificial intelligence supply chain, semiconductor localization, robotics industry, and biotechnology drug discovery [3][4] - China is currently two years behind the U.S. in the overall artificial intelligence supply chain, but the emergence of DeepSeek represents a significant breakthrough [3] - The investment opportunities in AI are primarily in Infrastructure as a Service (IaaS) and data center companies, with a long-term outlook for AI applications like AI glasses and toys, where Chinese companies have a competitive edge [3] Semiconductor Industry - There is optimism regarding semiconductor localization, particularly for semiconductor equipment companies [3] Robotics Industry - Asia is the largest market for industrial robots, and there is a growing recognition of the industry's potential, which is expected to surpass the scale of the electric vehicle industry [3] Biotechnology Sector - Chinese pharmaceutical companies have increasingly licensed new drugs to foreign firms, with China accounting for 28% of global patent contract value in 2024 [4] - China ranks second in new drug development pipeline contributions, following the U.S., due to significant investments in talent and innovation by the government [4] - The healthcare sector is becoming increasingly important, with global healthcare spending constituting 10%-20% of GDP, driven by aging populations and rising wealth [4] - The current era is described as a golden age for medical innovation, with biotechnology at the forefront [4]